Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:47:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:29:59.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details; this indicates an access restriction rather than an update to the study data.
    Difference
    23%
    Check dated 2026-09-20T11:23:44.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page’s footer now includes a 2023 U.S. NIH Grant/Contract acknowledgment, and the revision tag has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T00:35:33.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the study page, indicating a minor metadata update. There are no visible changes to the trial information presented.
    Difference
    0.0%
    Check dated 2026-08-08T22:30:58.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, reflecting a new build of the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:57:03.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.